ANL - Adlai Nortye Limited Forvard P/S multiplikatori

Adlai Nortye Ltd (ANL) korporativ emblemasi va logotipi

Xitoyda original dori vositalarining savdosi Adlai Nortye Ltd. (ANL) uchun barqaror daromad keltirmoqda, bu esa forward price-to-sales koeffitsiyentini qo'llab-quvvatlaydi, bunda metrika qiymati 32.60 darajasida turibdi. Rahbarlik jamoasi biotexnologik kengayishni jadallashtirish uchun global tajriba va tijorat hisob-kitoblarini birlashtiradi. Yuqori malakali mutaxassislarni jalb qilish bonus tizimi va qat'iy KPIlar orqali ta'minlanadi, bu esa innovatsion anti-tumor agentlarining ishlab chiqilishini rag'batlantiradi.

Adlai Nortye Limited - ANL Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 13.04.2026 - 17.11.2026)

Adlai Nortye Ltd - tahliliy kesimlar va asosiy koʻrsatkichlar (ANL)

- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
Kompaniyaning dastlabki tahlili:ANL (Adlai Nortye)
Adlai Nortye original mahsuloti

Forward P/S koeffitsiyenti Adlai Nortye Ltd. (ANL) kompaniyasining bozor qiymatini kutilayotgan daromadga nisbatan belgilaydi, bu esa potentsial sotib olishdan oldin yashirin biznes zaifliklarini aniqlash imkonini beradi. Forward P/S baholashidagi 32.60 ning joriy qiymati stress-test vositasi bo'lib xizmat qiladi va patent himoyasi hamda AQSh va Xitoyda antineoplastik dori vositalarining kengayayotgan qo'llanilishi orqali aktivning investitsiya jozibadorligini tasdiqlaydi.

Muhim raqobatchilar

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|Champions Oncology, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati XBiotech Inc XBIT|CVM: Forvard P/S multiplikatori|OSTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Radiopharm Theranostics Limited|Forvard P/S multiplikatori artivabio.com|Narxning prognoz qilingan daromadga nisbati Veru Pharma (VERU)|Forvard P/S multiplikatori Tempest Tx (TPST)|Narxning prognoz qilingan daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning prognoz qilingan daromadga nisbati|Mural Oncology - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori